Haemonetics (HAE) Treasury Shares (2016 - 2025)
Historic Treasury Shares for Haemonetics (HAE) over the last 16 years, with Q4 2025 value amounting to $357631.0.
- Haemonetics' Treasury Shares rose 7071.18% to $357631.0 in Q4 2025 from the same period last year, while for Dec 2025 it was $357631.0, marking a year-over-year increase of 7071.18%. This contributed to the annual value of $335843.0 for FY2025, which is 918.25% down from last year.
- According to the latest figures from Q4 2025, Haemonetics' Treasury Shares is $357631.0, which was up 7071.18% from $1.4 million recorded in Q3 2025.
- Over the past 5 years, Haemonetics' Treasury Shares peaked at $1.4 million during Q3 2025, and registered a low of $209494.0 during Q4 2024.
- Moreover, its 5-year median value for Treasury Shares was $366843.0 (2024), whereas its average is $541281.7.
- Its Treasury Shares has fluctuated over the past 5 years, first plummeted by 8324.59% in 2021, then soared by 15793.2% in 2023.
- Haemonetics' Treasury Shares (Quarter) stood at $248463.0 in 2021, then dropped by 15.08% to $211000.0 in 2022, then surged by 372.51% to $997000.0 in 2023, then crashed by 78.99% to $209494.0 in 2024, then skyrocketed by 70.71% to $357631.0 in 2025.
- Its Treasury Shares stands at $357631.0 for Q4 2025, versus $1.4 million for Q3 2025 and $363886.0 for Q2 2025.